COVID-19: TODAY`S TRENDS AND ECG MANIFESTATIONS OF CARDIOVASCULAR PATHOLOGY AGAINST THE BACKGROUND OF COVID-19 IN MILITARY PERSONNEL

This overview outlines aspects of the pathogenesis and ECG diagnostics of diseases of the cardiovascular system in COVID-19 and in post-covid syndrome, which occur in the patient, serving in the army. Included case reports, retrospective and prospective studies, systematic reviews and metanalyses, national guidelines and other descriptive reviews, results of own researches.

1. Patofiziologicheskie mekhanizmy i nozologicheskie formy serdechno-sosudistoj patologii pri COVID-19 / E.K. Serezhina, A.G. Obrezan / Kardiologiya. – 2020, – T. 60, № 8, – S. 23–26.

2. Rukovodstvo po diagnostike i lecheniyu boleznej sistemy krovoobrashcheniya v kontekste pandemii COVID-19 / E.V. Shlyahto [i dr.] // Rossijskij kardiologicheskij zhurnal. – 2020. – T. 25, № 3, – S. 129–148.

3. Klinicheskie osobennosti postkovidnogo perioda. Rezul‘taty mezhdunarodnogo registra «Analiz dinamiki komorbidnyh zabolevanij u pacientov, perenesshih inficirovanie SARS-CoV-2 (AKTIV SARS-CoV-2)». (12 mesyacev nablyudeniya) // Rossijskij kardiologicheskij zhurnal. 2023, T. 28, № 1, – S. 9–12.

4. Dolya E.M. SARS-COV-2 kak prichina razvitiya narushenij ritma serdca) / E.M. Dolya // Narusheniya ritma i provodimosti serdca: tezisy IX Evrazijskogo kongressa kardiologov. Online 24–25 maya 2021g.: tezisy / Medicinskaya akademiya imeni S.I. Georgievskogo FGAOU VO «KFU imeni V.I. Vernadskogo», 2 GBUZ RK «RKB imeni N.A. Semashko»; red.: E.M. Dolya [i dr.]. – Simferopol‘, Rossiya, 2021. – C. 14–15.

5. Porazhenie serdechno-sosudistoj sistemy pri koronavirusnoj infekcii. Profilaktika oslozhnenij, vozmozhnye posledstviya i dal‘nejshee lechenie / S.A. Bojcov [i dr.] // FGBU «NMIC kardiologii» Minzdrava Rossii 2020. – 54 slajda – (Obzornaya informaciya / FGBU «NMIC kardiologii im. akademika E. I. CHazova», Ministerstva zdravoohraneniya Rossijskoj Federacii).

6. Elektrokardiograficheskie priznaki narusheniya processov depolyarizacii (fragmentaciya QRS-kompleksa, fenomen rannej repolyarizacii zheludochkov i dr.) kak markery sistolicheskoj disfunkcii levogo zheludochka / M. S. Gordeeva [i dr.] // Rossijskij kardiologicheskij zhurnal. – 2022. T. 27, № 7. – S. 15–23.

7. Risk of QT interval prolongation associated with use of hydroxychloroquine with or without concomitant azithromycin among hospitalized patients testing positive for coronavirus disease 2019 (COVID-19) / NJ Mercuro [et al.] // JAMA Cardioloqy, 2020. T5, № 9. – P. 986–987.

8. Fomina, I.G. Gipertrofiya levogo zheludochka pri arterial‘noj gipertenzii i risk razvitiya aritmij / I.G. Fomina, T.A. D‘yakova // – Moskva: Moskovskaya medicinskaya akademiya im. I.M.Sechenova. Kardiovaskulyarnaya terapiya i profilaktika. – 2006. – Tom 5, № 8, – S.83–89.

9. EKG-diagnostika narushenij funkcii avtomatizma sinusovogo uzla, zameshchayushchih kompleksov i ritmov./ V.S. Zadionchenko [i dr.] // Russkij medicinskij zhurnal. – 2016. – Tom 9, – S. 530–539.

10. Prognostic value of myocardial injury in patients with COVID-19 / L Wang [et al.] // – Chinese Medical Association Publishing House Ltd., – 2020.

11. Fenomen ukorochennogo intervala PQ kak faktor razvitiya pri zanyatiyah fizichnskoj kul‘turoj i sportom / A. A. Svetlichkina [i dr.] // Zhurnal «Uchenye zapiski universiteta im. P. F. Lesgafta». – 2016. – № 9, – C. 171–174.

12. Prognosticheskaya znachimost‘ prodolzhitel‘nosti kompleksa QRS u pacientov s hronicheskoj serdechnoj nedostatochnost‘yu i fibrillyaciej predserdij: retrospektivnoe issledovanie / T.M. Uskach [i dr.] // Zhurnal «Terapevticheskij arhiv». – 2022. – Tom 94, № 4, – S. 503–510.

13. Clinical features of patients infected with 2019 novel coronavirus in Wuhan / S Huang [et al.] // – Chinese Academy of Medical Sciences, National Natural Science Foundation of China, and Beijing Municipal Science and Technology Commission. – 2020. – P. 497–506.

14. Coronavirus Disease (COVID-2019): situation report 124/ World Health Organization. – Available at: Last accessed. – 2020.

15. Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic / E Driggin [et al.] // – J Am Coll Cardiol., 2020. – P. 71–75.

16. Cardiovascular complications in COVID-19 / B. Long [et al.] // –J Emerg Med.,2020. – P. 352–371.

17. Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19 / C Chen [et al.] // – NCBI., 2020. – 48 (7). – P. 567–571.

18. Long B. Electrocardiographic manifestations of COVID-19 / Brit Long. – National laibrary of medicin, 2020. – P. 96–103 .

19. Cardiac tamponade secondary to COVID-19 / M.F. Dabbagh [et al.] // – JACC Case Rep. – American College of Cardiology Foundation, 2020. – P. 1326–1330.

20. Sorgente. A. The known into the unknown: Brugada syndrome and COVID-19 / A. Sorgente // – JACC Case Rep. – American College of Cardiology Foundation, 2020. – P. 1250–1251.

21. Asif T. Transient ST segment elevation in two patients with COVID-19 and a normal transthoracic echocardiogram / Asif T, Ali Z // – National laibrary of medicin // 7 (5) 2020. – P. 15–20.

22. QT prolongation, torsades de pointes and sudden death with short courses of chloroquine or hydroxychloroquine as used in COVID-19: a systematic review / I. Jankelson [et al.] // – Heart Rhythm., 17 (9), 2020. – P. 1472–1479.

23. Clinical course and factors associated with hospitalization and critical illness among COVID-19 patients in Chicago, Illinois / M Gottlieb [et al.] // – Acad Emerg Med. 27 (10), – 2020. – P. 963–973.

24. Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection / X. Zou X [et al.] // – Front Med. (14) 2. – 2020. – P. 185–192.

25. A pathological report of three COVID-19 cases by minimally invasive autopsies / Yao XH [et al.] // – National laibrary of medicin, 49(5), – 2020. – P. 411–417.

26. Electrocardiographic features of 431 consecutive, critically ill COVID-19 patients: an insight into the mechanisms of cardiac involvement / M Bertini [et al.] // – National laibrary of medicin Oxford University Press Europace. – P. 2020. – 258.

27. Sumanth D. Prabhu. Cytokine-induced modulation of cardiac function / Sumanth D. Prabhu. – Circ Res. – National laibrary of medicin 95 (12), – 2004. – P. 1140–1153.

28. Bidirectional relation between inflammation and coagulation / M. Levi [et al.] // – Circulation. 2004. – P. 2698–2704.

29. Pathological findings of COVID-19 associated with acute respiratory distress syndrome / Xu Z [et al.] // – Lancet Respir Med. 2020. – P. 420–422.

30. Pathological study of the 2019 novel coronavirus disease (COVID-19) through post-mortem core biopsies / Tian S [et al.] // – National laibrary of medicin. 2020. – P. 1007–1014.

31. Pulmonary and cardiac pathology in Covid-19: the first autopsy series from New Orleans / Fox SE [et al.] // – medRxiv. 2020.

32. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan / Wang D [et al.] // – China. JAMA. 2020. – P. 1061–1069.

33. Experience with hydroxychloroquine and azithromycin in the COVID-19 pandemic: implications for QT interval monitoring / A Ramireddy [et al.] // – Journal of American heart associatic. 2020. – P. 1–7.

34. Mitrofanova. L.B. Kliniko-morfologicheskoe i molekulyarno-biologicheskoe issledovanie miokarda u pacientov s COVID-19 / L.B. Mitrofanova // Rossijskij kardiologicheskij zhurnal. – 2022. – Tom 27, № 7, – S. 147–156.

35. Clinical characteristics of Covid-19 in New York City / P. Goyal [et al.] // – N Engl J Med. 7 (№ 5). – 2020. – P. 2372–2374.

36. Clinical features of 85 fatal cases of COVID-19 from Wuhan. A retrospective observational study / Y Du [et al.] // – Am J Respir Crit Care Med. – 2020. – P. 1372–1379.

37. Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection / S. Lei [et al.] // – E Clin Med. – 2020.

38. Cardiovascular disease, drug therapy, and mortality in Covid-19 / MR Mehra [et al.], – N Engl J Med. 2020.

39. Clinical and cardiac characteristics of COVID-19 mortalities in a diverse New York City cohort / MP Abrams [et al.], – J Cardiovasc Electrophysiol. 2020.

40. Electrocardiogram analysis of patients with different types of COVID-19 / Y. Wang [et al.], – Ann Noninvasive Electrocardiol. – 2020.

41. Cardiovascular manifestations and treatment considerations in covid-19 / Y Kang [et al.], – Heart. – 2020. – P. 1132–1141.

42. Initial precipitants and recurrence of atrial fibrillation / Wang EY[et al.] // – Circ Arrhythm Electrophysiol. 2020.

43. Atrial arrhythmias in a patient presenting with coronavirus disease-2019 (COVID-19) infection / Seecheran R, [et al.] // – J Investig Med High Impact Case Rep. 2020.